HydraFacial to go public via $1.1 bln deal with former Allergan CEO-backed SPAC

Reuters
2020/12/09

Dec 9 (Reuters) - A blank-check acquisition firm cofounded by the former chief executive officer of Allergan, Brent Saunders, will merge with beauty company HydraFacial in a deal valued at $1.1 billion including debt, the companies said on Wednesday.

HydraFacial's merger with Saunder's Vesper Healthcare Acquisition Corp will result in the Long Beach, California-based company listing on the Nasdaq.

The deal consists of $975 million payable upon completion and $75 million after certain acquisitions are completed by the combined company.

This adds to a wave of recent deals by so-called SPACs or special purpose acquisition companies, shell vehicles that raise money in an initial public offering to buy and then merge with another company, typically within two years.

Vesper went public in November, just a few months after AbbVie Inc closed its blockbuster $63 billion deal for Allergan, securing access to the anti-wrinkle injection Botox.

HydraFacial's skin-cleansing products are available in over 87 countries. The company was acquired by private equity firms Linden and DWHP in 2016.

(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

((Manas.Mishra@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 806749 2709))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10